{{Protein
| Name = 腎病2，特發性，類固醇抵抗性<br>(足蛋白)
| caption = 
| image = 
| width = 
| HGNCid = 13394
| Symbol = NPHS2
| AltSymbols = 
| EntrezGene = 7827
| OMIM = 604766
| RefSeq = NM_014625
| UniProt = Q9NP85
| PDB = 
| ECnumber = 
| Chromosome = 1
| Arm = q
| Band = 25
| LocusSupplementaryData = -q31
}}

'''足蛋白'''（{{lang|en|podocin}}、{{lang|en|nephrosis 2, idiopathic, steroid-resistant}}）即[[腎|腎臟]]的組成[[腎單位|腎元]]之[[腎小體|腎小體]]內的[[鮑氏囊|鮑氏囊]]上之[[足細胞|足細胞]][[濾過裂隙|裂隙隔膜]](slit diaphragm)的蛋白質成分。[[腎小球|腎小球毛細血管內皮細胞]]，[[腎小球基底膜|腎小球基底膜]]及裂隙隔膜充當的[[腎小球|腎小球]]濾過屏障。<ref>{{Cite journal|title=Update on the glomerular filtration barrier|url=https://pubmed.ncbi.nlm.nih.gov/19374010/|last=Jarad|first=George|last2=Miner|first2=Jeffrey H.|date=2009-05|journal=Current Opinion in Nephrology and Hypertension|issue=3|doi=10.1097/mnh.0b013e3283296044|volume=18|pages=226–232|issn=1473-6543|pmc=2895306|pmid=19374010}}</ref>足蛋白基因[[NPHS2|NPHS2]]的突變能引起[[腎病症候群|腎病症候群]](NS)，如[[局灶節段性腎小球硬化症|局灶節段性腎小球硬化症]](FSGS)或[[微小病變|微小病變]](MCD)。<ref>{{Cite journal|title=Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome|url=https://pubmed.ncbi.nlm.nih.gov/19713307/|last=Mollet|first=Géraldine|last2=Ratelade|first2=Julien|date=2009-10|journal=Journal of the American Society of Nephrology: JASN|issue=10|doi=10.1681/ASN.2009040379|volume=20|pages=2181–2189|issn=1533-3450|pmc=2754108|pmid=19713307|last3=Boyer|first3=Olivia|last4=Muda|first4=Andrea Onetti|last5=Morisset|first5=Ludivine|last6=Lavin|first6=Tiphaine Aguirre|last7=Kitzis|first7=David|last8=Dallman|first8=Margaret J.|last9=Bugeon|first9=Laurence}}</ref>

==參見==
*[[NPHS2|NPHS2]]
*[[足細胞|足細胞]]

==註釋==
{{reflist}}
{{Biochem-stub}}
[[Category:蛋白质|Category:蛋白质]]